SOLIQUA 100/33 is an injectable prescription medicine that contains 2 diabetes medicines, insulin glargine 100 Units/mL and lixisenatide, that may improve blood sugar (glucose) control in adults with type 2 diabetes, when used with diet and exercise in people who are not controlled with long-acting (basal) insulin (less than 60 units daily) or lixisenatide
The Problem with Unsupervised Medication Use Some people may be tempted to mix and match these medications because they have leftovers from a previous prescription or because they believe they can boost a lower dose
Rule on Negative Option Marketing
In the UK, most B12 supplements are regulated as food supplements rather than medicines
Research focus centers on receptor affinity dynamics and how the compound coordinates signals within complex metabolic frameworks
Journal reference: Martinelli, S., Mazzotta, A., Longaroni, M., & Petrucciani, N